In the latest session, T2 Biosystems Inc (NASDAQ: TTOO) closed at $3.00 down -1.64% from its previous closing price of $3.05. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 334049 shares were traded. TTOO stock price reached its highest trading level at $3.1580 during the session, while it also had its lowest trading level at $2.8400.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of T2 Biosystems Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Alliance Global Partners on January 27, 2021, Downgraded its rating to Neutral and sets its target price to $2.40 from $2.60 previously.
On October 08, 2020, BTIG Research started tracking the stock assigning a Buy rating and target price of $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 28 ’23 when CR Group L.P. sold 7,148,945 shares for $0.16 per share. The transaction valued at 1,125,959 led to the insider holds 0 shares of the business.
CR Group L.P. sold 5,981,202 shares of TTOO for $1,145,998 on Sep 27 ’23. The 10% Owner now owns 571,796 shares after completing the transaction at $0.19 per share. On Sep 26 ’23, another insider, CR Group L.P., who serves as the 10% Owner of the company, sold 5,392,920 shares for $0.20 each. As a result, the insider received 1,082,359 and left with 1,050,192 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TTOO now has a Market Capitalization of 14.85M and an Enterprise Value of 40.00M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34. Its current Enterprise Value per Revenue stands at 3.64 whereas that against EBITDA is -0.96.
Stock Price History:
Over the past 52 weeks, TTOO has reached a high of $70.00, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is 4.6042, while the 200-Day Moving Average is calculated to be 12.5495.
Shares Statistics:
For the past three months, TTOO has traded an average of 340.65K shares per day and 318k over the past ten days. Insiders hold about 38.19% of the company’s shares, while institutions hold 4.42% stake in the company. Shares short for TTOO as of Mar 15, 2024 were 295.39k with a Short Ratio of 0.87, compared to 423.97k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.99% and a Short% of Float of 7.19%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$2.2 for the current quarter, with a high estimate of -$2.2 and a low estimate of -$2.2, while EPS last year was -$141. The consensus estimate for the next quarter is -$2.27, with high estimates of -$2.27 and low estimates of -$2.27.
Analysts are recommending an EPS of between -$18.52 and -$18.52 for the fiscal current year, implying an average EPS of -$18.52. EPS for the following year is -$6.36, with 1 analysts recommending between -$6.36 and -$6.36.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $2M this quarter.It ranges from a high estimate of $2M to a low estimate of $2M. As of the current estimate, T2 Biosystems Inc’s year-ago sales were $5.48M, an estimated decrease of -63.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $2M, a decrease of -3.80% over than the figure of -$63.50% in the same quarter last year. There is a high estimate of $2M for the next quarter, whereas the lowest estimate is $2M.
A total of 1 analysts have provided revenue estimates for TTOO’s current fiscal year. The highest revenue estimate was $7M, while the lowest revenue estimate was $7M, resulting in an average revenue estimate of $7M. In the same quarter a year ago, actual revenue was $22.3M, down -68.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $10M in the next fiscal year. The high estimate is $10M and the low estimate is $10M. The average revenue growth estimate for next year is up 42.90% from the average revenue estimate for this year.
